Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCSW) Operating Expenses (2021 - 2025)

Historic Operating Expenses for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $2.1 million.

  • HeartSciences' Operating Expenses rose 452.29% to $2.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $8.2 million, marking a year-over-year increase of 1027.82%. This contributed to the annual value of $8.4 million for FY2025, which is 3223.58% up from last year.
  • Per HeartSciences' latest filing, its Operating Expenses stood at $2.1 million for Q4 2025, which was up 452.29% from $1.9 million recorded in Q3 2025.
  • Over the past 5 years, HeartSciences' Operating Expenses peaked at $2.4 million during Q1 2025, and registered a low of $676174.0 during Q3 2021.
  • For the 5-year period, HeartSciences' Operating Expenses averaged around $1.6 million, with its median value being $1.7 million (2022).
  • As far as peak fluctuations go, HeartSciences' Operating Expenses surged by 11167.05% in 2022, and later crashed by 1928.73% in 2023.
  • HeartSciences' Operating Expenses (Quarter) stood at $956856.0 in 2021, then surged by 85.49% to $1.8 million in 2022, then decreased by 11.41% to $1.6 million in 2023, then grew by 26.25% to $2.0 million in 2024, then rose by 4.52% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q4 2025, $1.9 million for Q3 2025, and $1.9 million during Q2 2025.